Allopurinol use and type 2 diabetes incidence among patients with gout: A VA retrospective cohort study.

ABSTRACT: To assess the impact of allopurinol on diabetes in a retrospective cohort of Veterans' Affairs patients with gout.The New York Harbor VA computerized patient record system was searched to identify patients with an ICD-9 code for gout meeting at least 4 modified 1977 American Rheumatology Association gout diagnostic criteria. Patients were divided into subgroups based on >30 continuous days of allopurinol, versus no allopurinol. New diagnoses of diabetes, defined according to American Diabetes Association diagnostic criteria or clinical documentation explicitly stating a new diagnosis of diabetes, were identified during an observation period from January 1, 2000 through December 31, 2015.Six hundred six gout patients used allopurinol >30 continuous days, and 478 patients never used allopuri

SUBMITTER: Slobodnick A 

PROVIDER: S-EPMC7458166 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature